Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation.

OBJECTIVE: In-stent restenosis (ISR) is regarded as a critical limiting factor in stenting for coronary heart disease (CHD). Recent research has shown that fasting residual cholesterol (RC) has been shown to have a substantial impact on coronary heart disease. Unfortunately, there have not been much data to bear out the relationship between RC and ISR. Then, the predictive value of RC for in-stent restenosis in patients with coronary heart disease was analyzed. PATIENTS AND METHODS: Aiming to explore the relationship between RC and ISR, we designed a retrospective study of patients with CHD after drug-eluting stent (DES) implantation, combining the data from a public database and selecting the best-fitting model by comparing the optical subset with least absolute shrinkage and selection operator (LASSO) regression.
RESULTS: Analysis of the abovementioned two models showed that the optical subset optimal subset model, which was based on RC, creatine, history of diabetes, smoking, multi-vessel lesions (2 vessels or more lesions), peripheral vascular lesions (PAD), and blood uric acid, had a better fit (AUC = 0.68), and that RC was an independent risk factor for ISR in the abovementioned two models. Notwithstanding its limitation, this study does suggest that RC has good predictive value for ISR.
CONCLUSION: Remnant cholesterol is an independent risk factor for in-stent restenosis after percutaneous coronary intervention (PCI) and is a reliable predictor of ISR.

Introduction

It is a truth universally acknowledged that Cardiovascular disease is a significant killer. In terms of coronary artery disease treatment, PCI has significantly improved symptomatic relief and quality of life in patients with coronary artery disease, and it is now firmly established as an effective treatment.1 However, the use of stents has always been limited by the occurrence of ISR.2 ISR and target lesion revascularization are significantly reduced with DES compared to bare-metal stents (BMS), but they are not completely eliminated. ISR after DES implantation, which occurs in 3–20% of cases, is a common clinical condition that should not be overlooked.3–5 What is more, the occurrence of ISR has a significant impact on the quality of life and long-term prognosis of patients.

An increasing number of studies have shown that dyslipidemia and ISR are indissolubly linked.6 To the best of our knowledge, the majority of the previous related literature7,8 has concentrated on investigating the impact of low-density lipoprotein cholesterol (LDL-C) levels on ISR. However, a growing number of studies have demonstrated that patients are still at considerable risk of developing cardiovascular disease even after lowering LDL-C to recommended concentrations and controlling other risk factors (eg, hypertension and diabetes). Nonetheless, an extensive protocol demonstrated that RC reflects more of the state of lipid metabolism than LDL-C, and an increasing number of scholars have noted that high levels of remnant cholesterol may also be an important pathogenic risk factor for the development of cardiovascular events.9–14

Unfortunately, there have not been much data to bear out the relationship between RC and ISR. What is more, most of the published studies8,10,11,15 are retrospective with small sample sizes and use multi-factor logistic regression statistics. It is well known that retrospective studies have many confounding factors and that multifactor logistic regression may suffer from overfitting and covariance, so we attempted to address this by reducing the dimensionality16 (using LASSO regression). Furthermore, we selected the best-fitting model by comparing the optical subset with LASSO regression, and exploring the relationship between RC and ISR.

Hence, we designed a retrospective study of patients with CAD after DES implantation, combining the data from a public database to explore the relationship between ISR and RC. And it was found that fasting RC levels were significantly and positively linked with the development of in-stent restenosis, indicating that RC has a strong prognostic value for ISR.

Patients and Methods

Study Population

Our consist of two parts: one from public databases and one from data collected retrospectively at the Enshi Tujia and Miao Autonomous Prefectures. The public data was obtained from the “DATADRY AD” database, a public, non-profit computerized database established by the Rich Healthcare Group in China (). We downloaded the raw data shared by Yao et al29 from: long-term follow-up results in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents: results from a single high-volume PCI Center. Furthermore, the raw data is freely accessible to the public. The original study enrolled 2533 participants who underwent PCI between July 2009 and August 2011, at a single high-volume PCI center in China. The study, covered by the data from the public database, was conducted in accordance with the Declaration of Helsinki and did not require patient consent, referring to the original research articles.

For our data, we retrospectively collected data from Enshi Hospital on patients who underwent percutaneous coronary drug-eluting stent implantation between 2017 and 2020 (research approval was obtained from Ethical Committees of Central Hospital of Enshi Tujia and Miao Autonomous Prefecture). We combined the data from a public database with our data to retrospectively analyze the relationship between RC and ISR.

Finally, 668 subjects were included in our study for analysis (Figure 1).

Figure 1

The selective procession of the participants.

Variable Extraction from Public Databases

For public data, variables were extracted as follows: general information about the patient (age, gender, smoking status, history of diabetes, history of heart failure, history of atrial fibrillation, history of peripheral vascular disease, history of hypertension), laboratory data including total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), serum creatinine (SCR), uric acid (UA), and total bilirubin (TBIL).

Laboratory Analysis for Our Data

Fasting blood samples were collected prior to coronary procedures for baseline PCI and follow-up angiography. Baseline indicators include age, gender, smoking status, underlying diseases (including hypertension, diabetes, stroke), and coronary artery disease at the time of the first drug-eluting stent implantation. The RC level was calculated as TC minus LDL-C and HDL-C, according to the relevant literature.9

Coronary Angiography and Evaluation of ISR for Our Data

All the patients mentioned in our data underwent DES implantation at our catheterization center. Patients were divided into ISR and non-ISR groups based on angiographic follow-up results. The main outcome measure was ISR, which is defined as ≥50% luminal narrowing at follow-up angiography.

Statistic Analysis

Differences in baseline information between the two groups were compared. Continuous variables were expressed as mean (standard deviation, SD) in a normal distribution with chi-square, and differences in continuous variables between the ISR and non-ISR groups were tested using a t-test. When the distribution was skewed, data was expressed as medians (25th and 75th percentiles: P25, P75) and compared using the Mann–Whitney U-test. Categorical variables were presented as numbers and percentages and compared using the Wilcoxon test.

The data was subjected to internal validation of the data according to a ratio of 3:7. Optimal subset + multi-factor logistic regression analysis (Model 1) was used to investigate the relationship between each variable and ISR. Considering the large number of covariates affecting ISR, we used Lasso logistic regression, a regularization method for creating parsimonious models to identify the critical determinants of in-stent restenosis and compare the strengths and weaknesses of the models. The LASSO model applied to high-dimensional data reduction was used to select the best predictive features among risk factors for ISR patients. Features with nonzero coefficients in the LASSO regression model were selected. The feature selected in the LASSO regression model (Model 2) was then incorporated into the predictive model using multivariable logistic regression analysis. The characteristics were evaluated using an odds ratio (OR) with a 95% confidence interval (CI) and a P-value. Variables with a P value of 0.05 were included in the model, while those associated with disease and treatment characteristics were considered in the model. We used receiver operating characteristic curve (ROC) analysis to assess the fit of the two models. A 2-tailed P < 0.05 was considered significant.

Results

Baseline Clinical Characteristics

Of the 668 patients who met the inclusion criteria, in-stent restenosis was observed in 192 of the 678 (40.3%) patients. Baseline characteristics were compared between 192 patients with ISR and 478 patients without ISR (Table 1).

Table 1

The Baseline Clinical Characteristics

Characteristics	Non-ISR	ISR	P value
	n = 476	n = 192
Gender, male, n (%)	320 (67.2)	143 (74.5)	0.081
Age			0.904
20—40	20 (4.0)	8 (4.0)
40—60	242 (51)	85 (48.2)
60—80	81 (44.3)	93 (48.4)
80—	5 (1.0)	4 (2.0)	1
Heart failure (%)	91 (19.1)	46 (24.0)	0.195
Atrial fibrillation (%)	8 (1.7)	3 (1.6)	1
Stroke (%)	22 (4.6)	11 (5.7)	0.689
Peripheral vascular disease (%)	8 (1.7)	13 (6.8)	0.002
Hypertension (%)	234 (49.2)	108 (56.2)	0.116
Diabetes (%)	91 (19.1)	47 (24.5)	0.149
Smoking (%)	187 (39.3)	96 (50.0)	0.014
Beta-blockers (%)	336 (70.6)	141 (73.4)	0.52
ACEI (%)	281 (59.0)	121 (63.0)	0.387
CCB (%)	84 (17.6)	33 (17.2)	0.977
Statin (%)	458 (96.2)	184 (95.8)	0.99
Multi-vessel lesions(%)	153 (32.1)	102 (53.1)	<0.001
Left main stem (%)	25 (5.3)	18 (9.4)	0.073
Left anterior descending branch (%)	388 (81.5)	173 (90.1)	0.009
Left Circumflex branch	0.51 (0.50)	0.59 (0.49)	0.054
Right Circumflex branch	0.50 (0.50)	0.60 (0.49)	0.013
Creatinine (mean (SD))	69.00 (17.70)	74.13 (23.32)	0.002
Uric acid (mean (SD))	311.65 (84.05)	317.01 (94.28)	0.472
Total Bilirubin (mean (SD))	10.52 (5.30)	11.42 (6.51)	0.062
Total cholesterol (mean (SD))	4.46 (1.11)	4.52 (1.09)	0.48
Triglyceride (mean (SD))	1.92 (1.45)	2.19 (1.72)	0.045
HDL (mean (SD))	1.07 (0.28)	1.00 (0.28)	0.006
LDL (mean (SD))	2.72 (0.92)	2.69 (0.88)	0.645
Lesion Vessel number (mean (SD))	1.48 (0.64)	1.56 (0.74)	0.134
Stent numbers (mean (SD))	2.10 (1.29)	2.13 (1.33)	0.807
Residual cholesterol (mean (SD))	0.67 (0.46)	0.84 (0.68)	<0.001

Abbreviations: ACEI, Angiotensin-converting enzyme inhibitor; CCB, Calcium channel antagonist; HDL-C, High-density lipoprotein cholesterol; LDL-C, Low-density lipoprotein cholesterol.

According to Table 1, the general conditions, such as age, sex, and history of hypertension, diabetes (DM), heart failure (HF), atrial fibrillation (AF), as well as stroke in both groups, were not statistically significant. However, the proportion of smokers in the ISR group was significantly higher than in the non-ISR group, as well as the proportion of patients with a history of peripheral vascular disease.

Regarding the PCI-related content, the proportion of patients with multiple lesions (2 vessels or more lesions) was significantly higher in the in-stent restenosis group compared with the control group, with a statistically significant difference [102 (53.1%) vs 153 (32.1%), p < 0.001]. Compared to the control group, the ISR group had a higher proportion of the target left anterior descending artery (LAD), [173 (90.1%) vs 388 (81.5%)], p = 0.009], while the vessel-right coronary artery (RCA) showed the opposite trend in the non-ISR group (p = 0.013). There was no significant difference in the number of stents and the number of diseased vessels between the two groups.

Regarding postoperative treatment, there were no differences between the groups.

In terms of liver and kidney function and thyroid function, creatinine levels were significantly higher in the ISR group than in the control group, and the differences were statistically significant [69 vs 74.13, p = 0.002], while there were no statistically significant differences between groups in indicators, such as blood uric acid (UA) and indirect bilirubin (BIL) (all p >0.05).

When talking to lipids, the levels of RC and TG in the ISR group were higher than those in the control group, and the differences were statistically significant (P < 0.05). The levels of HDL-C in the ISR group were significantly lower than in the non-ISR group. In contrast, the differences between LDL and TC did not differ between the two groups.

Comparison Between Logistic Regression Optimal Subset Model and LASSO Regression Model

For the selection of the optimal subset model (Model 1), all variables from the baseline information were included in the initial logistic regression model, and a multi-factor logistic regression was performed using the backward method to select the optimal subset based on the principle of choosing the model with the lowest AIC value as the optimal model. As shown in Table 2, we found that RC, creatine, history of diabetes, smoking, multi-vessel lesions (2 vessels or more lesions), peripheral vascular lesions (PAD), and blood uric acid were independent predictors for ISR after implantation of drug-eluting stents (AIC =−780.31).

Table 2

The Optimal Subset Regression Analysis of Predictive for ISR

	Multivariate Analysis
Variables	OR	95% CI		P
PAD	1.3924	1.0998	1.7629	0.0061
DM	1.0834	0.9812	1.1962	0.1129
Smoking	1.1061	1.0186	1.2012	0.0166
Multi-vessel	1.1238	1.0330	1.2227	0.0067
Cr	1.0018	0.9993	1.0044	0.1563
UA	0.9996	0.9991	1.0001	0.1281
RC	1.1524	1.0680	1.2435	0.0002

Abbreviations: PAD, peripheral vascular lesions; DM, Diabetes; Cr, Creatine; UA, Uric acid.

In terms of feature selection for the predictive model for the risk of developing in-stent restenosis in patients after PCI, based on the patients in the cohort (3:1 ratio), 22 features were reduced to 10 potential predictors and had nonzero coefficients in the LASSO regression model (Model 2, Figure 2). These factors included RC, age, PAD, history of hypertension, smoking, multi-vessel lesions, left main stem lesion, left anterior descending branch lesion, creatine, and HDL-C.

Figure 2

Feature selection using the LASSO binary logistic regression model.

The area under the ROC curve for the optimal subset based on the training set is 0.68 (Figure 3), which is slightly higher than the area under the ROC curve for the LASSO model (Figure 4). Therefore, we used the optimal subset to assess the predictive value of RC for ISR. And we could get the conclusion that RC played an important role in ISR and was also an independent risk factor for ISR.

Figure 3

The area under the ROC curve for the optimal subset.

Figure 4

The area under the ROC curve for the LASSO model.

Discussion

Dyslipidemia is a major pathogenic risk factor for atherosclerosis, and numerous studies6,9–12,17 have confirmed that dyslipidemia is not only an independent risk factor for CHD but also closely related to ISR. For the postoperative lipid management of PCI patients, lipid-lowering therapy is recommended for the secondary prevention of PCI patients according to the guidelines for PCI.18 The clinical benefits of lipid-lowering therapy should be long term.19–21 For patients following PCI, the known risk factors for in-stent restenosis include patient factors, biomarkers, coronary artery lesion factors, stent-related factors, and operative factors,22,23 but a significant number of studies9,12,13,19,23 have confirmed that lipid management is vital among these factors. It is suggested that monitoring and managing lipids should prioritize the treatment and prevention of CHD patients following drug-eluting stent (DES) implanted.

LDL-C is currently the leading indicator used for lipid monitoring in lipid management, but it is found that the incidence of coronary heart disease and ISR is still high, although it targets LDL-C levels in patients at high risk for coronary heart disease or post-PCI.9 Furthermore, several studies have shown that elevated RC significantly increases the risk of cardiovascular events.9,10

Although there have been many clinical studies9,10,24 on lipid control in patients with in-stent restenosis, most have focused on LDL and few on remnant cholesterol. What is more, current articles are limited by small sample sizes and differing methodological approaches. This study is a retrospective analysis of the relationship between fasting remnant cholesterol levels and the occurrence of restenosis after PCI in Chinese patients with coronary artery disease after DES implantation, combining the data from a public database aimed at standardizing lipid-lowering medications. Fasting remnant cholesterol level was found to be closely related to ISR occurrence and to be an independent risk factor for ISR. This finding is consistent with previous studies that found that elevated fasting remnant cholesterol levels increased the degree of coronary atherosclerotic stenosis. Furthermore, in this study, a retrospective analysis of patients with ISR revealed that RC, creatine, history of diabetes, smoking, multi-vessel lesions (2 vessels or more lesions), peripheral vascular lesions, and blood uric acid were all independent risk factors for restenosis.

Regarding remnant cholesterol as an independent risk factor for ISR and as a strong predictor of ISR, the following mechanisms are currently documented: the pathogenic mechanisms of RC are currently considered to include oxidative stress as well as inflammatory mechanisms. Anette Varbo proposed15,25–27 that RC is similar to LDL-C in terms of atherogenicity. The mechanism is similar in that macrophages and smooth muscle cells capture RC and turn into foam cells, which eventually lead to atherosclerotic plaque formation. Due to its large size, RC enters the arterial wall at a slightly slower rate, but its ability to bind to macrophages and smooth muscle cells is ten times greater than that of LDL-C, which is the mechanism of oxidative stress that makes RC pathogenic.28 Regarding the inflammatory mechanism, on the one hand, RC entering the arterial wall can exert inflammatory effects, and the triacylglycerol component of RC entering the arterial wall can trigger local and even systemic low-grade inflammation.28 It was found28 that remnant cholesterol lipoproteins (RLP) can stimulate inflammatory factors in endothelial cells and promote monocyte adhesion. On the other hand, elevated TC in the circulating blood can also lead to systemic inflammation. In summary, when abnormal lipid metabolism leads to an increased concentration of circulating RC, more and more RC enters the arterial wall, contributing to foam cell formation, which also triggers a systemic inflammatory response, ultimately leading to cardiovascular events.

Conclusion

Fasting remnant cholesterol levels were significantly and positively correlated with the occurrence of in-stent restenosis in our post-PCI population. Therefore, remnant cholesterol is an essential predictor of ISR after PCI and an essential guide for different lipid-lowering therapies in this population. The risk assessment model (model1) based on RC, creatine, history of diabetes, smoking, multi-vessel lesions (2 vessels or more lesions), PAD, and blood uric acid after PCI had good predictive value as well as goodness of fit for in-stent restenosis. Nevertheless, the research still has several limitations. First of all, its validity is limited by the retrospective design with an inadequate level of evidence. Secondly, this is an observational single-center registry and may have an inherent bias common to this type of study.